Literature DB >> 9544905

Growth status in children with cystic fibrosis based on the National Cystic Fibrosis Patient Registry data: evaluation of various criteria used to identify malnutrition.

H C Lai1, M R Kosorok, S A Sondel, S T Chen, S C FitzSimmons, C G Green, G Shen, S Walker, P M Farrell.   

Abstract

OBJECTIVES: The objectives of this study were to determine growth status and to identify malnutrition with various anthropometric indicators in children with cystic fibrosis (CF) based on cross-sectional analysis of the 1993 National CF Patient Registry data.
METHODS: Heights and weights of 13,116 children with CF were evaluated with percentile, percent of reference median, Z-score, and percent ideal weight-for-height based on National Center for Health Statistics/Centers for Disease Control growth references. Malnutrition was defined by four criteria: (1) height-for-age <5th percentile ("stunting") or weight-for-age <5th percentile ("wasting") (2) height-for-age <90% of reference median or weight-for-age <80% of reference median, (3) height-for-age <5th percentile or percent ideal weight-for-height <85%, and (4) height-for-age <90% of reference median or weight-for-height <85% of reference median.
RESULTS: Mean and median height- and weight-for-age were found to be at the 30th and 20th percentiles in children with CF. Malnutrition (height- or weight-for-age <5th percentile) was particularly pronounced in infants (47%) and adolescents (34%) and patients with newly diagnosed CF (44%). A significant sex difference (p < 0.01) in the occurrence of stunting (height-for-age <5th percentile) was observed during adolescence: boys 11 to 14 years of age showed lower occurrence of stunting (19%) compared with girls (29%), whereas the opposite trend was observed at 15 to 18 years (34% in male patients vs 28% in female patients).
CONCLUSION: Twenty percent of all children in the 1993 National CF Patient Registry were <5th percentile for height- or weight-for-age. A significant discrepancy was found when different criteria were used to distinguish "stunting" versus "wasting" in malnourished children with CF.

Entities:  

Mesh:

Year:  1998        PMID: 9544905     DOI: 10.1016/s0022-3476(98)70024-1

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  41 in total

Review 1.  Growth and growth charts in cystic fibrosis.

Authors:  Leena Patel; Moira Dixon; T J David
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

2.  An automated communication system in a contact registry for persons with rare diseases: scalable tools for identifying and recruiting clinical research participants.

Authors:  R L Richesson; H S Lee; D Cuthbertson; J Lloyd; K Young; J P Krischer
Journal:  Contemp Clin Trials       Date:  2008-09-07       Impact factor: 2.226

3.  Growth and pulmonary outcomes during the first 2 y of life of breastfed and formula-fed infants diagnosed with cystic fibrosis through the Wisconsin Routine Newborn Screening Program.

Authors:  Sarah A Jadin; Grace S Wu; Zhumin Zhang; Suzanne M Shoff; Benjamin M Tippets; Philip M Farrell; Tami Miller; Michael J Rock; Hara Levy; HuiChuan J Lai
Journal:  Am J Clin Nutr       Date:  2011-03-23       Impact factor: 7.045

4.  Comparing the Use of Centers for Disease Control and Prevention and World Health Organization Growth Charts in Children with Cystic Fibrosis through 2 Years of Age.

Authors:  Zhumin Zhang; Suzanne M Shoff; HuiChuan J Lai
Journal:  J Pediatr       Date:  2015-08-19       Impact factor: 4.406

5.  Predictive 5-year survivorship model of cystic fibrosis.

Authors:  T G Liou; F R Adler; S C Fitzsimmons; B C Cahill; J R Hibbs; B C Marshall
Journal:  Am J Epidemiol       Date:  2001-02-15       Impact factor: 4.897

6.  Recovery of birth weight z score within 2 years of diagnosis is positively associated with pulmonary status at 6 years of age in children with cystic fibrosis.

Authors:  Huichuan J Lai; Suzanne M Shoff; Philip M Farrell
Journal:  Pediatrics       Date:  2009-02       Impact factor: 7.124

7.  Early life growth patterns persist for 12 years and impact pulmonary outcomes in cystic fibrosis.

Authors:  Don B Sanders; Zhumin Zhang; Philip M Farrell; HuiChuan J Lai
Journal:  J Cyst Fibros       Date:  2018-02-01       Impact factor: 5.482

8.  Vitamin d deficiency in cystic fibrosis.

Authors:  William B Hall; Amy A Sparks; Robert M Aris
Journal:  Int J Endocrinol       Date:  2010-01-28       Impact factor: 3.257

9.  Oxandrolone Improves Height Velocity and BMI in Patients with Cystic Fibrosis.

Authors:  Todd Varness; Erin E Seffrood; Ellen L Connor; Michael J Rock; David B Allen
Journal:  Int J Pediatr Endocrinol       Date:  2010-01-24

Review 10.  Endocrine Disorders in Cystic Fibrosis.

Authors:  Scott M Blackman; Vin Tangpricha
Journal:  Pediatr Clin North Am       Date:  2016-08       Impact factor: 3.278

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.